Meningococcal Conjugate Vaccine Market Value set to reach industry expectations (2017-2023)

Meningococcal vaccine is used to prevent contagious infection of the membranes that surround the brain and spinal cord caused by Neisseria meningitides. Three types of vaccines are present to act against meningococcal disease which target serogroups A, C, W-135, and Y of meningococcus. These vaccines are mainly used to immunize infants and children against invasive diseases caused by Neisseria meningitides.

The major factors that contribute to the growth of the meningococcal conjugate vaccine market include increasing prevalence of diseases caused by microorganisms such as Neisseria meningitides, improving healthcare infrastructure, development of quality vaccines at an affordable price, and growing awareness about meningococcal vaccination & associated immunization. However, high costs, adverse effects of vaccines, and stringent government regulations hamper the growth of the global meningococcal conjugate vaccine market. Development of combination vaccines and large numbers of mergers & acquisition strategies among key vendors are expected to propel the growth of the market in the near future.

Send Enquiry on this report @ https://www.alliedmarketresearch.com/purchase-enquiry/4143

The global meningococcal conjugate vaccine market is segmented on the basis of composition, brand, end user, and region. On the basis of composition, the market is bifurcated into mono and combination vaccines. Based on brand, the market is segmented into Menactra, Menveo, NeisVac-C, Nimenrix, and others which include Meningitec, menAfriVac, Menjugate, and NmVac4-DT. On the basis of end user, the market is segmented into children, preteens or teens, and adults. Geographically, the market has been analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The key players that operate in this market include Sanofi Pasteur, Pfizer Inc., GlaxoSmithKline plc., Hualan Biological Engineering Inc., JN International Medical Corporation, Baxter International Inc., Merck & Co., Inc., Serum Institute of India Pvt. Ltd., Biomed Pvt. Ltd., and Novartis AG.

Key Benefits

• The study provides an in-depth analysis of the global meningococcal conjugate vaccine market with current trends and future estimations to elucidate imminent investment pockets.
• The report provides information about the current and upcoming trends in the global meningococcal conjugate vaccine market from 2016 to 2023, which helps determine prevailing opportunities.
• Comprehensive analysis of factors that drive and restrict the growth of the global meningococcal conjugate vaccine market has been provided.
• Identification of factors that are instrumental in changing the market scenario, rise in opportunities, and identification of key companies that can influence this market on a global and regional scale have been provided.
• Key market players within the market have been profiled in this report and their strategies thoroughly analyzed, which help understand the competitive outlook of the global meningococcal conjugate vaccine market.

For More Info Visit @ https://www.alliedmarketresearch.com/meningococcal-conjugate-vaccine-market

Meningococcal Conjugate Vaccine Market Key Segments:

By Composition

• Mono Vaccines
• Combination Vaccines

By Brand

• Menactra
• Menveo
• NeisVac-C
• Nimenrix
• Others (Meningitec, menAfriVac, Menjugate, and NmVac4-DT)

By End User

• Children
• Preteens or Teens
• Adults

About us

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.

Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.